What is Myositis Clinical Trial Consortium (MCTC)?

MCTC is a collaborative international alliance dedicated to facilitating, coordinating, and conducting clinical trials and related supportive clinical research in idiopathic inflammatory myopathies (IIM) and other related autoimmune myositis. 

This partnership works to advance the discovery of effective treatments for autoimmune myositis by integrating a diverse group of clinical investigators, researchers, medical centers, research staff, and other key stakeholders. 

MCTC focus on various subtype of myositis, including polymyositis (PM), immune necrotizing myopathy (IMNM), dermatomyositis (DM), amyopathic dermatomyositis (CADM), anti-synthetase syndrome (ASS), juvenile myositis, cancer-associated autoimmune myositis, connective-tissue disease associated myositis, and inclusion body myositis (IBM).

Physicians

Health-care professionals, Research staffs

Patients, patient support organizations

Industry partners

Our Mission

  • Facilitate clinical trial planning, including study feasibility and site selection.

  • Offer junior investigators/centers comprehensive training in study protocol, disease classification and assessment, and outcome measures to establish the readiness for further myositis clinical trials and research.

  • Develop a multi-center prospective observational myositis registry with data collection at individual centers for future myositis clinical trials and related research.

  • Provide preliminary analysis, feasibility assessments, collaboration and grant support for participating investigators.

  • Establish collaborative clinical trials and related studies among various participating centers, such as to develop and validate novel classification criteria and outcome measures for future myositis clinical trials.

  • Generate interdisciplinary discussion and consensus on standards for myositis clinical trial design, protocols, guidelines, ethics, and outcome measures.

Want to join or support Myositis clinical trials and studies?

Myositis Clinical Trial Consortium (MCTC)  is open to investigators , study coordinators and study team members, patients and patient support organizations, and industry partners who are interested in participating in myositis clinical trials and research. 

Becoming a MCTC member